Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Debt / NOTE 2.500% 2/1
-
Market price (% of par)
-
167.14%
-
Total 13F principal
-
$197,124,000
-
Principal change
-
+$3,524,000
-
Total reported market value
-
$329,441,000
-
Number of holders
-
21
-
Value change
-
-$121,050,589
-
Number of buys
-
10
-
Number of sells
-
12
Institutional Holders of AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 as of Q4 2014
As of 31 Dec 2014,
AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 was held by
21 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$197,124,000
in principal (par value) of the bond.
The largest 10 bondholders included
DEERFIELD MANAGEMENT CO, STEELHEAD PARTNERS LLC, Citadel Advisors LLC, WOLVERINE ASSET MANAGEMENT LLC, Calamos Advisors LLC, Castle Creek Arbitrage, LLC, PUTNAM INVESTMENTS LLC, Mohican Financial Management, LLC, BASSO CAPITAL MANAGEMENT L.P., and Ameriprise Financial Inc.
This page lists
21
institutional bondholders reporting positions
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.